Order Article Reprints

Bermejo-Guerrero L, de Fuenmayor-Fernández de la Hoz CP, Guerrero-Molina MP, Martín-Jiménez P, Blázquez A, Serrano-Lorenzo P, Lora D, Morales-Conejo M, González-Martínez I, López-Jiménez EA, et al. Serum GDF-15 Levels Accurately Differentiate Patients with Primary Mitochondrial Myopathy, Manifesting with Exercise Intolerance and Fatigue, from Patients with Chronic Fatigue Syndrome. Journal of Clinical Medicine. 2023; 12(6):2435. https://doi.org/10.3390/jcm12062435

Bermejo-Guerrero, Laura, Carlos Pablo de Fuenmayor-Fernández de la Hoz, María Paz Guerrero-Molina, Paloma Martín-Jiménez, Alberto Blázquez, Pablo Serrano-Lorenzo, David Lora, Montserrat Morales-Conejo, Irene González-Martínez, Elena Ana López-Jiménez, and et al. 2023. "Serum GDF-15 Levels Accurately Differentiate Patients with Primary Mitochondrial Myopathy, Manifesting with Exercise Intolerance and Fatigue, from Patients with Chronic Fatigue Syndrome" Journal of Clinical Medicine 12, no. 6: 2435. https://doi.org/10.3390/jcm12062435

Bermejo-Guerrero, L., de Fuenmayor-Fernández de la Hoz, C. P., Guerrero-Molina, M. P., Martín-Jiménez, P., Blázquez, A., Serrano-Lorenzo, P., Lora, D., Morales-Conejo, M., González-Martínez, I., López-Jiménez, E. A., Martín, M. A., & Domínguez-González, C. (2023). Serum GDF-15 Levels Accurately Differentiate Patients with Primary Mitochondrial Myopathy, Manifesting with Exercise Intolerance and Fatigue, from Patients with Chronic Fatigue Syndrome. Journal of Clinical Medicine, 12(6), 2435. https://doi.org/10.3390/jcm12062435